Do Malassezia species play a role in exacerbation of scalp psoriasis?

[1]  S. Akçağlar,et al.  Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis , 2013, International journal of dermatology.

[2]  M. Hantschke,et al.  The Malassezia Genus in Skin and Systemic Diseases , 2012, Clinical Microbiology Reviews.

[3]  P. Sfikakis,et al.  Pharmacodynamics of TNF-α inhibitors in psoriasis , 2011, Expert review of clinical pharmacology.

[4]  T. Boekhout.  Malassezia and the skin , 2010 .

[5]  S. Chimenti,et al.  Scalp psoriasis: European consensus on grading and treatment algorithm , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  H. Zeraati,et al.  Distribution of Malassezia species in patients with psoriasis and healthy individuals in Tehran, Iran , 2008, Journal of cutaneous pathology.

[7]  M. Muto,et al.  Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real‐time polymerase chain reaction assay , 2007, The British journal of dermatology.

[8]  T. Sugita,et al.  Molecular analysis of Malassezia microflora in the lesional skin of psoriasis patients , 2007, The Journal of dermatology.

[9]  E. Roé,et al.  Acute generalized skin eruption due to adalimumab: report of two cases , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  S. Dogra,et al.  Malassezia and psoriasis: Koebner's phenomenon or direct causation? , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  Chi-Hong Tseng,et al.  Molecular Analysis of Fungal Microbiota in Samples from Healthy Human Skin and Psoriatic Lesions , 2006, Journal of Clinical Microbiology.

[12]  H. Ashbee.  Recent developments in the immunology and biology of Malassezia species. , 2006, FEMS immunology and medical microbiology.

[13]  G. Donnarumma,et al.  Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur , 2005, Archives of Dermatological Research.

[14]  T. Boekhout,et al.  Skin diseases associated with Malassezia species. , 2004, Journal of the American Academy of Dermatology.

[15]  G. Donnarumma,et al.  Possible role of Malassezia furfur in psoriasis: modulation of TGF‐β1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis‐affected patients , 2004, Journal of cutaneous pathology.

[16]  A. Prohić,et al.  Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healthy subjects. , 2003, Acta dermatovenerologica Croatica : ADC.

[17]  P. Nordin,et al.  Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol. , 2003, Acta dermato-venereologica.

[18]  S. Watanabe,et al.  The skin fungus‐induced Th1‐ and Th2‐related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  R. Summerbell,et al.  Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. , 2001, Medical mycology.

[20]  V. Vicente,et al.  Black fungi: clinical and pathogenic approaches. , 2000, Medical mycology.

[21]  Á. Casaño,et al.  Malassezia globosa as the causative agent of pityriasis versicolor , 2000 .

[22]  Á. Casaño,et al.  [Isolation and identification of Malassezia spp. In pytiriasis versicolor, seborrheic dermatitis and healthy skin.]. , 1999 .

[23]  M. Rubio,et al.  [Mycological view of dermatophytes in humans.]. , 1999, Revista iberoamericana de micologia.

[24]  E. Guého,et al.  Mycology of pityriasis versicolor , 1999 .

[25]  J. Garioch,et al.  Differential T‐cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis , 1997, The British journal of dermatology.

[26]  T. Bunse,et al.  Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients. , 1996, Acta dermato-venereologica.

[27]  I. Jónsdóttir,et al.  Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.

[28]  L. Plotkin,et al.  Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis , 1994, Clinical and experimental dermatology.

[29]  D. Leung,et al.  A potential role for superantigens in the pathogenesis of psoriasis. , 1993, The Journal of investigative dermatology.

[30]  B. Elewski.  Does pityrosporum ovale have a role in psoriasis? , 1990, Archives of dermatology.

[31]  L. King,et al.  Ketoconazole's Inhibition of Fungal Antigen‐Induced Thymidine Uptake by Lymphocytes from Patients with Psoriasis , 1986, The American journal of the medical sciences.

[32]  S. Shuster,et al.  RESPONSE OF SCALP PSORIASIS TO ORAL KETOCONAZOLE , 1985, The Lancet.

[33]  E. Rosenberg,et al.  Improvement of psoriasis of the scalp with ketoconazole. , 1982, Archives of dermatology.

[34]  E. Rosenberg,et al.  Patch tests with killed sonicated microflora in patients with psoriasis. , 1982, Archives of dermatology.

[35]  S. Shapiro,et al.  Letter: ABO blood types in congenital heart-disease. , 1975, Lancet.